论文部分内容阅读
With the proven overall benefit of neoadjuvant chemotherapy in patients with locally advanced gastric cancer,there has come a need to discriminate responders from non-responders.In this article,the current role of anatomical and molecular imaging in the prediction of response to neoadjuvant therapy in gastric cancer is outlined and future prospects are discussed.
With the proven overall benefit of neoadjuvant chemotherapy in patients with locally advanced gastric cancer, there has come come a need to discriminate responders from nonresponders. This article role of anatomical and molecular imaging in the prediction of response to neoadjuvant therapy in gastric cancer is outlined and future prospects are discussed.